ErbB2 is a tumor associated antigen and a suitable therapeutic target in Wilms tumor
- J. H. Pinthus*
- , E. Fridman
- , B. Dekel
- , I. Goldberg
- , K. Kaufman-Francis
- , Z. Eshhar
- , A. Harmelin
- , G. Rechavi
- , O. Mor
- , J. Ramon
- , Y. Mor
*Corresponding author for this work
- Tel Aviv University
- Sheba Medical Center at Tel Hashomer
- Weizmann Institute of Science
- Quark Pharmaceuticals Inc
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations